Wendy Johnson

Wendy Johnson

Director/Board Member chez EXAGEN INC.

Fortune : 1 590 $ au 31/03/2024

72 ans
Health Technology
Consumer Services
Finance

Profil

Wendy S.
Johnson
founded Palkion, Inc. in 2008, where she worked as President and Aires Pharmaceuticals, Inc. in 2006, where she worked as President & Chief Executive Officer from 2006 to 2014.
Ms. Johnson also currently works at Exagen, Inc., as Independent Director from 2020, Gemini Advisors, as Managing Director, Accelerator Services Corp, as Operating Partner, Reneo Pharmaceuticals, Inc., as Chief Business Officer from 2021, and Formation Bio Inc, as Advisor.
Ms. Johnson also formerly worked at AmpliPhi Biosciences Corp., as Director from 2017 to 2019, US Food & Drug Administration, as Assistant Director-Devices & Radiological Health, Center for Devices & Radiological Health, as Assistant Director from 1976 to 1986, Synbiotics LLC, as Manager-Business Development from 1988 to 1990, Women First HealthCare, Inc., as Vice President-Business Development from 1998 to 2000, ProQuest Management LLC, as Venture Partner from 2005 to 2014, Salmedix, Inc., as Senior Vice President-Corporate Development from 2001 to 2004, MorphoSys AG, as Member-Supervisory Board from 2015 to 2022, Prizm Pharmaceuticals, Inc., as Principal, Mutual of New York Life, as Vice President, Selective Genetics, Inc., as Vice President-Corporate Development & Operations from 1994 to 1998, Murex Corp., as Manager-International Business Development from 1988 to 1990, and Cytel Corp., as VP-Business Development & Regulatory Affairs from 1990 to 1994.
Ms. Johnson received her Masters Business Admin degree in 1986 from Loyola Marymount University, undergraduate degree in 1974 from the University of Maryland, and graduate degree from Drexel University College of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/06/2023 1 000 ( 0,01% ) 1 590 $ 31/03/2024

Postes actifs de Wendy Johnson

SociétésPosteDébut
RENEO PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2021
EXAGEN INC. Director/Board Member 01/10/2020
Consultant / Advisor -
Chief Executive Officer -
Private Equity Investor -
Tous les postes actifs de Wendy Johnson

Anciens postes connus de Wendy Johnson

SociétésPosteFin
MORPHOSYS AG Director/Board Member 18/05/2022
Chief Operating Officer 30/01/2017
Private Equity Investor 30/03/2014
Chief Executive Officer 01/03/2014
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Wendy Johnson

Formation de Wendy Johnson

Loyola Marymount University Masters Business Admin
University of Maryland Undergraduate Degree
Drexel University College of Medicine Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Wendy Johnson

Relations

100 +

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
MORPHOSYS AG

Health Technology

EXAGEN INC.

Health Services

RENEO PHARMACEUTICALS, INC.

Health Technology

Entreprise privées17

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Prizm Pharmaceuticals, Inc.

Health Technology

Mutual of New York Life /2 Hampton Inns/

Consumer Services

Health Technology

Government

Murex Corp.

Finance

Health Services

Cytel Corp.

Center for Devices & Radiological Health

Government

Commercial Services

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Wendy Johnson